Key result
Chemotherapy-induced cardiotoxicity in breast cancer patients requires new diagnostic methods for early detection of subclinical myocardial dysfunction to prevent irreversible heart failure.
Highlights the clinical need for novel imaging methods to detect early, subclinical chemotherapy-induced cardiotoxicity in breast cancer patients before irreversible heart failure develops.
No takes yet. Share an insight, caveat, or question.
Supports vigilant monitoring in breast cancer patients on chemotherapy; leaves open optimal early-detection strategies pending validation.
Florescu et al. (2011) conducted a review in Chemotherapy-induced cardiotoxicity in breast cancer. Chemotherapy was evaluated. Chemotherapy-induced cardiotoxicity in breast cancer patients requires new diagnostic methods for early detection of subclinical myocardial dysfunction to prevent irreversible heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: